IMCC logo

IM Cannabis (IMCC) Company Overview

Profile

Full Name:

IM Cannabis Corp.

Sector:

Healthcare

Industry:

Drug Manufacturers - Specialty & Generic

Country:

Israel

IPO:

May 20, 2020

Indexes:

Not included

Website:

http://imcannabis.com

Description:

IM Cannabis is a company that produces and sells medical and recreational cannabis products. Based in Israel, it focuses on high-quality cannabis cultivation, processing, and distribution. IM Cannabis aims to provide safe and effective products for patients and consumers in various markets around the world.

Key Details

Price

$1.88

Market Cap

$5.80 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$36.14 M(-13.45% YoY)

Annual EPS

-$3.29(+97.36% YoY)

PE Ratio

-

Annual ROE

-50.50%

Annual Debt To Equity

0.86

Beta

0.10

Events Calendar

Earnings

Next earnings date:

Mar 28, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

Mar 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jul 12, 2024

Analyst ratings

Recent major analysts updates

Dec 31, 21 Roth Capital
Buy
Oct 5, 21 Roth Capital
Buy

Screeners with IMCC included

Growing Shares Outstanding
High Piotroski score stocks
Stocks below SMA 200
Healthcare sector
All stocks
Small cap stocks
Israeli stocks
Stocks with low beta
Specialty & Generic Drug Manufacturers industry
NASDAQ earnings calendar

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$1.88
IMCC price is $1.88

Price All-time High

$27000.01
IMCC price is currently -99.99% below its historical high of $27000.01

Price Analysts Target

-
IMCC price consensus analysts' forecast is unknown

Price Most Recent Change

+3.3%
IMCC price was up +3.3% on Mar 6, 2025

Price YTD Change

-6%
IMCC price is down -6% since January 1st

Price 3-Year Change

-98.6%
IMCC price is down -98.6% over the past 3 years

Market cap

Market Cap

$5.80 M
IMCC market capitalization is $5.80 million

Market Cap 3-Year Change

-96.22%
IMCC market capitalization is down -96.22% over the past 3 years

Market Cap All-time High

$407.86 M
IMCC market capitalization is currently -98.58% below its historical high of $407.86 million

Market Cap Sector Rank

13.42%
IMCC market capitalization is higher than 13.42% of companies in Healthcare sector

Technical

Beta

0.10
IMCC beta is 0.10

200-day SMA

$2.54
IMCC price is currently -25.88% below its 200-day simple moving average

14-day RSI

32.56
IMCC 14-day relative strength index is 32.56

30-day Relative Volume

0.14
IMCC 30-day relative volume is 0.14

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$36.14 M
IMCC annual revenue is $36.14 million

Annual Revenue Analysts Estimate

$55.18 M
IMCC annual revenue is currently -34.50% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

-13.45%
IMCC annual revenue is down -13.45% year-on-year

Annual Revenue Sector Rank

44.68%
IMCC annual revenue is higher than 44.68% of companies in Healthcare sector

Profit

Annual Gross Profit

$7.29 M
IMCC annual gross profit is $7.29 million

Annual Gross Margin

20.17%
IMCC annual gross profit margin is 20.17%

Annual Operating Profit

-$9.02 M
IMCC annual operating income is -$9.02 million

Annual Operating Margin

-24.95%
IMCC annual operating profit margin is -24.95%

Annual Net Income

-$7.03 M
IMCC annual net profit is -$7.03 million

Annual Net Margin

-19.46%
IMCC annual net profit margin is -19.46%

EPS

Annual EPS

-$3.29
IMCC annual earnings per share is -$3.29

Annual EPS Analysts Estimate

-
IMCC annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

+97.36%
IMCC annual earnings per share is up +97.36% year-on-year

Annual EPS Sector Rank

31.17%
IMCC annual earnings per share is higher than 31.17% of companies in Healthcare sector

ROA & ROE

Annual ROA

-17.26%
IMCC annual return on assets is -17.26%

Annual ROE

-50.50%
IMCC annual return on equity is -50.50%

EBIT & EBITDA

Annual EBIT

-$4.29 M
IMCC annual earnings before interest & taxes is -$4.29 million

Annual EBITDA

-$2.07 M
IMCC annual EBITDA is -$2.07 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
IMCC price to earnings ratio value is unknown

PE Ratio Sector Rank

-
IMCC price to earnings ratio is unknown

PB Ratio

PB Ratio

1.32
IMCC price to book ratio is 1.32

PB Ratio Sector Rank

49.34%
IMCC price to book ratio is higher than 49.34% of companies in Healthcare sector

PS Ratio

PS Ratio

0.15
IMCC price to sales ratio is 0.15

PS Ratio Sector Rank

5.71%
IMCC price to sales ratio is higher than 5.71% of companies in Healthcare sector

Enterprise value

Enterprise Value

$15.94 M
IMCC enterprise value is $15.94 million

Enterprise Value Sector Rank

26.95%
IMCC enterprise value is higher than 26.95% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-3.67
IMCC EV/EBITDA is -3.67

EV/EBITDA Sector Rank

26.97%
IMCC EV/EBITDA is higher than 26.97% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

0.74
IMCC annual current ratio is 0.74

Annual Quick Ratio

0.44
IMCC annual quick ratio is 0.44

Leverage

Annual Debt To Equity

0.86
IMCC annual debt to equity ratio is 0.86

Annual Interest Coverage Ratio

-1.58
IMCC annual interest coverage ratio is -1.58

Risk & Stability

Piotroski F-Score

6
IMCC piotroski f-score is 6

Altman Z-Score

-6.63
IMCC altman z-score is -6.63

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$36.80 M
IMCC annual total assets is $36.80 million

Annual Non Current Assets

$18.50 M
IMCC annual long term assets is $18.50 million

Annual Current Assets

$18.29 M
IMCC annual total current assets is $18.29 million

Annual Cash & Cash Equivalents

$1.37 M
IMCC annual cash & cash equivalents is $1.37 million

Equity

Annual Book Value

$10.91 M
IMCC annual book value is $10.91 million

Annual Working Capital

-$6.44 M
IMCC annual working capital is -$6.44 million

Liabilities

Annual Total Liabilities

$26.47 M
IMCC annual total liabilities is $26.47 million

Annual Total Long Term Liabilities

$1.74 M
IMCC annual total long term liabilities is $1.74 million

Annual Current Liabilities

$24.73 M
IMCC annual total current liabilities is $24.73 million

Annual Accounts Payable

$6.95 M
IMCC annual accounts payable is $6.95 million

Debt

Annual Total Debt

$10.39 M
IMCC annual total debt is $10.39 million

Annual Total Debt 1-Year Change

+22.25%
IMCC annual total debt is up +22.25% year-on-year

Annual Long Term Debt

$911.40 K
IMCC annual long term debt is $911.40 thousand

Annual Short Term Debt

$9.48 M
IMCC annual short term debt is $9.48 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$45.16 M
IMCC annual total expenses is $45.16 million

Annual Operating Expenses

$16.31 M
IMCC annual total operating expenses is $16.31 million

Annual Cost Of Goods Sold

$28.85 M
IMCC annual cost of goods sold is $28.85 million

Annual SGA

$14.10 M
IMCC annual SGA is $14.10 million

Annual D&A

$2.22 M
IMCC annual depreciation & amortization is $2.22 million

Annual Interest Expense

$2.72 M
IMCC annual interest expense is $2.72 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$5.98 M
IMCC annual cash flow from operations is -$5.98 million

Annual CFO 1-Year Change

+38.45%
IMCC annual cash flow from operations is up +38.45% year-on-year

Annual CFI

-$875.40 K
IMCC annual cash flow from investing activities is -$875.40 thousand

Annual CFI 1-Year Change

+25.71%
IMCC annual cash flow from investing activities is up +25.71% year-on-year

Annual CFF

$6.97 M
IMCC annual cash flow from financing activities is $6.97 million

Annual CFF 1-Year Change

+90.54%
IMCC annual cash flow from financing activities is up +90.54% year-on-year

Free CashFlow

Annual FCF

-$6.41 M
IMCC annual free cash flow is -$6.41 million

Annual FCF 1-Year Change

+41.27%
IMCC annual free cash flow is up +41.27% year-on-year

CAPEX

Annual CAPEX

$430.30 K
IMCC annual capital expenditures is $430.30 thousand

Annual CAPEX 1-Year Change

-64.16%
IMCC annual capital expenditures is down -64.16% year-on-year

Institutional Ownership

Similar stocks

GLTO logo
Galecto (GLTO)
SILO logo
Silo Pharma (SILO)
EVOK logo
Evoke Pharma (EVOK)
XBIO logo
Xenetic Biosciences (XBIO)
Dogwood Therapeutics (DWTX)
OTRK logo
Ontrak (OTRK)
VRAX logo
Virax Biolabs Group Limited (VRAX)
FRTX logo
Fresh Tracks Therapeutics (FRTX)
NLSP logo
NLS Pharmaceutics AG (NLSP)

FAQ

  • What is the ticker symbol for IM Cannabis?
  • Does IM Cannabis pay dividends?
  • What sector is IM Cannabis in?
  • What industry is IM Cannabis in?
  • What country is IM Cannabis based in?
  • When did IM Cannabis go public?
  • Is IM Cannabis in the S&P 500?
  • Is IM Cannabis in the NASDAQ 100?
  • Is IM Cannabis in the Dow Jones?
  • When was IM Cannabis's last earnings report?
  • When does IM Cannabis report earnings?

What is the ticker symbol for IM Cannabis?

The ticker symbol for IM Cannabis is NASDAQ:IMCC

Does IM Cannabis pay dividends?

No, IM Cannabis does not pay dividends

What sector is IM Cannabis in?

IM Cannabis is in the Healthcare sector

What industry is IM Cannabis in?

IM Cannabis is in the Drug Manufacturers - Specialty & Generic industry

What country is IM Cannabis based in?

IM Cannabis is headquartered in Israel

When did IM Cannabis go public?

IM Cannabis's initial public offering (IPO) was on May 20, 2020

Is IM Cannabis in the S&P 500?

No, IM Cannabis is not included in the S&P 500 index

Is IM Cannabis in the NASDAQ 100?

No, IM Cannabis is not included in the NASDAQ 100 index

Is IM Cannabis in the Dow Jones?

No, IM Cannabis is not included in the Dow Jones index

When was IM Cannabis's last earnings report?

IM Cannabis's most recent earnings report was on Nov 14, 2024

When does IM Cannabis report earnings?

The next expected earnings date for IM Cannabis is Mar 28, 2025